Roche Molecular Systems, Inc. · Class II · Cleared Jun 1, 2023
| K-number | K231306 |
| Device name | cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | QQX |
| Device class | Class II |
| Decision date | Jun 1, 2023 |
| Decision | Substantially Equivalent |
| Regulation | 866.3981 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov